Evolutionary changes in antimicrobial resistance of invasive Neisseria meningitidis isolates in Belgium from 2000 to 2010: Increasing prevalence of penicillin nonsusceptibility

Antimicrobial Agents and Chemotherapy

Volumn 56, Issue 5, 2012, Pages 2268-2272

  Bertrand, Sophie ^a   Carion, Françoise ^a   Wintjens, René ^b   Mathys, Vanessa ^a   Vanhoof, Raymond ^a  

^a SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

^b UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; PENICILLIN G; RIFAMPICIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BELGIUM; CONTROLLED STUDY; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; MENINGOCOCCOSIS; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EVOLUTION; NEISSERIA MENINGITIDIS; NONHUMAN; PHENOTYPE; PREVALENCE; PRIORITY JOURNAL;

3' FLANKING REGION; ALLELES; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; BELGIUM; BIOLOGICAL EVOLUTION; CEFTRIAXONE; DRUG RESISTANCE, BACTERIAL; GENE FREQUENCY; GENES, BACTERIAL; HUMANS; LONGITUDINAL STUDIES; MENINGOCOCCAL INFECTIONS; MICROBIAL SENSITIVITY TESTS; NEISSERIA MENINGITIDIS; PENICILLIN G; PENICILLIN-BINDING PROTEINS; SEQUENCE ANALYSIS, DNA;

EID: 84860164332     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.06310-11     Document Type: Article

References (26)

1. Abdillahi H, Poolman JT. 1988. Definition of meningococcal class 1 OMP subtyping antigens by monoclonal antibodies. FEMS Microbiol. Immunol. 1:139-144. (Pubitemid 19007195)
2. Antignac A, et al. 2003. Correlation between alterations of the penicillin-binding protein 2 and modifications of the peptidoglycan structure in Neisseria meningitidis with reduced susceptibility to penicillin G. J. Biol. Chem. 278:31529-31535. (Pubitemid 37048330)
3. Antignac A, Kriz P, Tzanakaki G, Alonso JM, Taha MK. 2001. Polymorphism of Neisseria meningitidis penA gene associated with reduced susceptibility to penicillin. J. Antimicrob. Chemother. 47:285-296. (Pubitemid 32229570)
4. Arreaza L, et al. 2004. Sequencing of Neisseria meningitidis penA gene: the key to success in defining penicillinGbreakpoints. Antimicrob. Agents Chemother. 48:358-359. (Pubitemid 38040224)
5. Berron S, Vazquez JA. 1994. Increase in moderate penicillin resistance and serogroup C in meningococcal strains isolated in Spain. Is there any relationship? Clin. Infect. Dis. 18:161-165. (Pubitemid 24055253)
6. Birtles A, et al. 2005. Multilocus sequence typing of Neisseria meningitidis directly from clinical samples and application of the method to the investigation of meningococcal disease case clusters. J. Clin. Microbiol. 43:6007-6014. (Pubitemid 43100652)
7. Canica M, Dias R, Ferreira E. 2004. Neisseria meningitidis C:2b:P1.2,5 with intermediate resistance to penicillin, Portugal. Emerg. Infect. Dis. 10:526-529. (Pubitemid 38314488)
8. Caugant DA. 2008. Genetics and evolution of Neisseria meningitidis: importance for the epidemiology of meningococcal disease. Infect. Genet. Evol. 8:558-565.
9. Caugant DA, Maiden MC. 2009. Meningococcal carriage and disease - population biology and evolution. Vaccine 27(Suppl. 2):B64-B70.
10. De Schrijver K, Maes I. 2003. An outbreak of serogroup C meningococcal disease in the province of Antwerp (Belgium) in 2001-2002. Eur. J. Epidemiol. 18:1073-1077. (Pubitemid 37339372)
11. du Plessis M, von Gottberg A, Cohen C, de Gouveia L, Klugman KP. 2008. Neisseria meningitidis intermediately resistant to penicillin and causing invasive disease in South Africa in 2001 to 2005. J. Clin. Microbiol. 46:3208-3214.
12. Hill DJ, Griffiths NJ, Borodina E, Virji M. 2010. Cellular and molecular biology of Neisseria meningitidis colonization and invasive disease. Clin. Sci. (London) 118:547-564.
13. Lapadula G, et al. 2009. Imported ciprofloxacin-resistant Neisseria meningitidis. Emerg. Infect. Dis. 15:1852-1854.
14. Maiden MC. 1998. The Impact of Molecular Techniques on the Study of Meningococcal Disease. Methods Mol. Med. 15:265-291.
15. Sanford JP, et al. 2011. The Sanford guide to antimicrobial therapy 2010-2011. Jeb C. Sanford, Wavre, Belgium.
16. Skoczynska A, Alonso JM, Taha MK. 2008. Ciprofloxacin resistance in Neisseria meningitidis, France. Emerg. Infect. Dis. 14:1322-1323.
17. Skoczynska A, Ruckly C, Hong E, Taha MK. 2009. Molecular characterization of resistance to rifampicin in clinical isolates of Neisseria meningitidis. Clin. Microbiol. Infect. 15:1178-1181.
18. Stefanelli P. 2011. Emerging resistance in Neisseria meningitidis and Neisseria gonorrhoeae. Expert. Rev. Anti. Infect. Ther. 9:237-244.
19. Stefanelli P, et al. 2001. Rifampicin-resistant meningococci causing invasive disease: detection of point mutations in the rpoB gene and molecular characterization of the strains. J. Antimicrob. Chemother. 47:219-222. (Pubitemid 32149533)
20. Taha MK, Giorgini D, Ducos-Galand M, Alonso JM. 2004. Continuing diversification of Neisseria meningitidis W135 as a primary cause of meningococcal disease after emergence of the serogroup in 2000. J. Clin. Microbiol. 42:4158-4163. (Pubitemid 39296139)
21. Taha MK, et al. 2010. Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrob. Agents Chemother. 54:3651-3658.
22. Taha MK, et al. 2007. Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob. Agents Chemother. 51:2784 -2792.
23. Thulin S, Olcen P, Fredlund H, Unemo M. 2006. Total variation in the penA gene of Neisseria meningitidis: correlation between susceptibility to beta-lactam antibiotics and penA gene heterogeneity. Antimicrob. Agents Chemother. 50:3317-3324. (Pubitemid 44527504)
24. Van Looveren M, Carion F, Vandamme P, Goossens H. 1998. Surveillance of meningococcal infections in Belgium. Clin. Microbiol. Infect. 4:224 -228.
25. Van Looveren M, et al. 1998. Molecular epidemiology of recent belgian isolates of Neisseria meningitidis serogroup B. J. Clin. Microbiol. 36:2828-2834. (Pubitemid 28429399)
26. Wu HM, et al. 2009. Emergence of ciprofloxacin-resistant Neisseria meningitidis in North America. N. Engl. J. Med. 360:886-892.